Detalles de la búsqueda
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547895
2.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334548
3.
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
Ann Surg
; 270(5): 747-754, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634178
4.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042063
5.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
6.
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
Cancer
; 121(18): 3290-7, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26052689
7.
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study.
Cancer Treat Res Commun
; 37: 100781, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38039763
8.
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
J Clin Oncol
; 41(2): 255-265, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969830
9.
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Exp Hematol Oncol
; 12(1): 63, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480095
10.
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Dig Liver Dis
; 55(4): 541-548, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115817
11.
Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma.
Endosc Ultrasound
; 11(6): 487-494, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537386
12.
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59.
Biomedicines
; 10(5)2022 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625947
13.
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.
J Clin Oncol
; 40(3): 262-271, 2022 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662180
14.
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
Eur J Cancer
; 162: 138-147, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995900
15.
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.
Oncologist
; 16(9): 1228-38, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859820
16.
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
Clin Res Hepatol Gastroenterol
; 45(3): 101541, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33055007
17.
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial.
Clin Cancer Res
; 27(20): 5638-5646, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083233
18.
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.
J Clin Oncol
; 39(29): 3242-3250, 2021 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34288696
19.
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRIâ¯+â¯Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.
Dig Liver Dis
; 53(4): 420-426, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358124
20.
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302).
Clin Colorectal Cancer
; 19(4): 285-290, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32921581